Skip to content

Travere Therapeutics, Inc.

TVTX Nasdaq SEC CIK 1438533

Follow Travere Therapeutics Weekly email: filings, results, news

News

7 stories filed under Travere Therapeutics

Markets

Thread · 4 stories

Travere Therapeutics stock hits 52-week high at 67.97 USD

Markets 21 d ago

IBD Stock Of The Day, Travere Therapeutics, Tests Another Breakout. Can The Stock Get Any 'Sweeter?'

Markets 34 d ago

Travere Therapeutics: Valuation Suggests A Buy

Markets 36 d ago

Travere Therapeutics at canaccord growth conference: rare-disease push widens

Markets 44 d ago 2 sources

Earnings

Thread · 2 stories

Travere Therapeutics, Inc. 2026 Q2 - Results - Earnings Call Presentation

Earnings 49 d ago

Travere Therapeutics Q2 Earnings: Why I'm Downgrading To Hold (Again)

Earnings 49 d ago

More coverage

Stifel raises Travere Therapeutics price target on FSGS launch

Markets 50 d ago

Next results

NOV3

Q1 2026 results

Tuesday · estimated from the filing cadence

Profile

Headquarters: SAN DIEGO, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 7 stories clustered from the RSS aggregator